Thierry Heles, editor of Global University Venturing, takes an alternate look at one of last week's corporate venturing deals.

Biotechnology spinout Aprea has secured the largest funding round of any Karolinska Development portfolio company to date.

Imperial Innovations led the round, while Consort Medical also participated as it enters into a collaboration agreement with the retinal disease treatment developer.

Stanford spinout Sirona Genomics produces technology to map and manage bloody type, organ and other genomic assessments more accurately in a database.

Newly launched spinout Z53 Therapeutics is working on cancer treatments that exploit a discovery of how to repair a protein that suppresses tumour formation.

Imperial Innovations leads a funding round for Precision Ocular, while Consort Medical also participates and enters a collaboration agreement with the spinout.

The Bradford spinout will conduct a phase 1 clinical trial for a potential cancer treatment following a $894,000 cancer charity grant.